Get a 360º view and stay up-to-date on kidney transplant with content selected for you.
The role of long-lived plasma cells in antibody-mediated rejection of kidney transplantation: An update
Clinical perspectives towards improving risk stratification strategy for renal transplantation outcomes in Indian patients
Anti‐IL‐2R blockers comparing with polyclonal antibodies: Higher risk of rejection without negative mid‐term outcomes after ABO‐incompatible kidney transplantation
r-ATG induces human lymphocyte activation, proliferation, and apoptosis in the absence of complement: An experimental study
Grafalon® vs. Thymoglobuline® as an induction agent in renal transplantation – A retrospective study
Disclaimer: The images depicted here are fictitious and meant for illustrative purpose only. Any resemblance to any person, living or dead is purely coincidental.